| __timestamp | MorphoSys AG | Neurocrine Biosciences, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 77000 | 14400000 |
| Thursday, January 1, 2015 | 77000 | 33800000 |
| Friday, January 1, 2016 | 97000 | 35900000 |
| Sunday, January 1, 2017 | 33000 | 1254000 |
| Monday, January 1, 2018 | 1796629 | 4889000 |
| Tuesday, January 1, 2019 | 12085198 | 7400000 |
| Wednesday, January 1, 2020 | 9174146 | 10100000 |
| Friday, January 1, 2021 | 32200000 | 14300000 |
| Saturday, January 1, 2022 | 48620000 | 23200000 |
| Sunday, January 1, 2023 | 58355000 | 39700000 |
| Monday, January 1, 2024 | 34000000 |
Unleashing insights
In the ever-evolving landscape of biotechnology, understanding cost structures is pivotal. This analysis delves into the cost of revenue trends for Neurocrine Biosciences, Inc. and MorphoSys AG from 2014 to 2023. Neurocrine Biosciences, Inc. has shown a steady increase in its cost of revenue, peaking at approximately $39.7 million in 2023, a significant rise from $1.44 million in 2014. This represents a staggering growth of over 2,600% over the decade.
Conversely, MorphoSys AG's cost of revenue surged from a modest $77,000 in 2014 to an impressive $58.4 million in 2023, marking an exponential increase of over 75,000%. This dramatic rise underscores the company's expanding operational scale and market reach. Such insights are crucial for investors and stakeholders aiming to navigate the complexities of the biotech sector.
Cost of Revenue Comparison: Eli Lilly and Company vs Neurocrine Biosciences, Inc.
Cost of Revenue Comparison: AbbVie Inc. vs Neurocrine Biosciences, Inc.
Analyzing Cost of Revenue: GSK plc and MorphoSys AG
Neurocrine Biosciences, Inc. vs Bio-Techne Corporation: Efficiency in Cost of Revenue Explored
Cost of Revenue Comparison: Neurocrine Biosciences, Inc. vs Telix Pharmaceuticals Limited
Cost of Revenue Comparison: Neurocrine Biosciences, Inc. vs Bausch Health Companies Inc.
Cost of Revenue: Key Insights for Neurocrine Biosciences, Inc. and Mesoblast Limited
Comparing Cost of Revenue Efficiency: Dr. Reddy's Laboratories Limited vs MorphoSys AG
Cost of Revenue Trends: Perrigo Company plc vs MorphoSys AG
Cost of Revenue Trends: ACADIA Pharmaceuticals Inc. vs MorphoSys AG
Cost of Revenue Comparison: MorphoSys AG vs Taro Pharmaceutical Industries Ltd.
Comparing Cost of Revenue Efficiency: MorphoSys AG vs MiMedx Group, Inc.